According to Monsanto Company - the combination of a new biotechnology trait and seed treatment system in soybeans is demonstrating strong early season performance. The company says varieties with the Genuity™ Roundup Ready 2 Yield® trait and Acceleron™ seed treatment are showing an advantage over competitive soybean products and first-generation traits in many parts of the U.S. This is the first year of commercialization for both technologies. They will serve as base platforms underpinning Monsanto’s sustainability goal of doubling soybean yields by 2030.

This new biotech trait is designed to boost yield potential - and the seed treatment system helps maximize crop performance potential from the beginning. Monsanto’s U.S. oilseed product management director Jennifer Ralston says more than 16-thousand farmers across the Corn Belt are experiencing the breakthrough benefits of this trait and seed treatment. And early observations are giving Monsanto confidence that this trait-and-treatment tandem will be the industry leader in yield performance.

Monsanto says early season data from soybeans with the Genuity Roundup Ready 2 Yield trait and Acceleron for next season demonstrates consistent improvement in plant stand and seedling vigor - as compared to untreated soybeans and competitive germplasm treated with commercial seed treatments. Field trials were conducted in multiple locations across more than 10 states.